Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.82+0.02 (+0.10%)
Close on Nov 18, 2026Market cap $936.43MP/E –Yield –
Silence Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Silence Therapeutics's revenue for the twelve months ending Sep 30, 2026 was $456.00K, down 98.2% year over year. For fiscal 2025 it was $559.00K, down 98.7% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $559.00K | -98.7% |
| FY2024 | Dec 31, 2024 | $43.26M | +36.7% |
| FY2023 | Dec 31, 2023 | $31.64M | +46.1% |
| FY2022 | Dec 31, 2022 | $21.66M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0 | -100.0% |
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $422.00K | +197.2% |
| Q4 FY2025 | Dec 31, 2025 | $34.00K | -99.9% |
| Q3 FY2025 | Sep 30, 2025 | $159.00K | -89.4% |
| Q2 FY2025 | Jun 30, 2025 | $224.00K | -70.4% |
| Q1 FY2025 | Mar 31, 2025 | $142.00K | -99.1% |
| Q4 FY2024 | Dec 31, 2024 | $25.31M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.50M | – |
| Q2 FY2024 | Jun 30, 2024 | $756.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $15.70M | – |
See a number that looks wrong?